IT1238072B - Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina - Google Patents

Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina

Info

Publication number
IT1238072B
IT1238072B IT01911290A IT1911290A IT1238072B IT 1238072 B IT1238072 B IT 1238072B IT 01911290 A IT01911290 A IT 01911290A IT 1911290 A IT1911290 A IT 1911290A IT 1238072 B IT1238072 B IT 1238072B
Authority
IT
Italy
Prior art keywords
calcitonin
pharmaceutical compositions
dosage forms
oral administration
oral
Prior art date
Application number
IT01911290A
Other languages
English (en)
Other versions
IT9019112A0 (it
IT9019112A1 (it
Inventor
Filippo Lattanzi
Riccardo Vanni
Original Assignee
Sclavo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sclavo Spa filed Critical Sclavo Spa
Priority to IT01911290A priority Critical patent/IT1238072B/it
Publication of IT9019112A0 publication Critical patent/IT9019112A0/it
Priority to MX2403990A priority patent/MX24039A/es
Priority to US07/640,811 priority patent/US5441933A/en
Priority to KR1019910000675A priority patent/KR910014128A/ko
Priority to EP19910100509 priority patent/EP0438147A3/en
Priority to CA002034519A priority patent/CA2034519A1/en
Priority to JP3016832A priority patent/JPH04210924A/ja
Publication of IT9019112A1 publication Critical patent/IT9019112A1/it
Application granted granted Critical
Publication of IT1238072B publication Critical patent/IT1238072B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT01911290A 1990-01-19 1990-01-19 Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina IT1238072B (it)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IT01911290A IT1238072B (it) 1990-01-19 1990-01-19 Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina
MX2403990A MX24039A (es) 1990-01-19 1990-12-28 Composiciones farmaceuticas que contienen una calcitonina como principio activo.
US07/640,811 US5441933A (en) 1990-01-19 1991-01-14 Pharmaceutical compositions and dosage forms for the oral administration of calcitonin
KR1019910000675A KR910014128A (ko) 1990-01-19 1991-01-17 칼시토닌의 경구투여용 약제학적 조성물 및 용량형
EP19910100509 EP0438147A3 (en) 1990-01-19 1991-01-17 Pharmaceutical compositions and dosage forms for the oral administration of calcitonin
CA002034519A CA2034519A1 (en) 1990-01-19 1991-01-18 Pharmaceutical compositions and dosage forms for the oral administration of calcitonin
JP3016832A JPH04210924A (ja) 1990-01-19 1991-01-18 カルシトニンの経口投与用の製薬組成物及び投薬形態

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT01911290A IT1238072B (it) 1990-01-19 1990-01-19 Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina

Publications (3)

Publication Number Publication Date
IT9019112A0 IT9019112A0 (it) 1990-01-19
IT9019112A1 IT9019112A1 (it) 1991-07-19
IT1238072B true IT1238072B (it) 1993-07-03

Family

ID=11154741

Family Applications (1)

Application Number Title Priority Date Filing Date
IT01911290A IT1238072B (it) 1990-01-19 1990-01-19 Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina

Country Status (7)

Country Link
US (1) US5441933A (it)
EP (1) EP0438147A3 (it)
JP (1) JPH04210924A (it)
KR (1) KR910014128A (it)
CA (1) CA2034519A1 (it)
IT (1) IT1238072B (it)
MX (1) MX24039A (it)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9120672D0 (en) * 1991-09-28 1991-11-06 Ciba Geigy Ag Pharmaceutical compositions
EP0839526A3 (en) 1996-10-31 1999-01-07 Takeda Chemical Industries, Ltd. Solid pharmaceutical preparation with fast buccal disintegration or dissolution
PT1121103E (pt) 1998-05-18 2007-02-28 Takeda Pharmaceutical Comprimidos de desintegração oral compreendendo um benzimidazole
ES2237121T3 (es) 1998-07-28 2005-07-16 Takeda Pharmaceutical Company Limited Preparacion solida disgregable rapidamente.
UA75569C2 (en) * 1998-12-01 2006-05-15 Reddys Lab Ltd Dr Pharmaceutical composition of thiadiazolidinedione and method for its manufacture
US7067116B1 (en) * 2000-03-23 2006-06-27 Warner-Lambert Company Llc Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1
US7049283B2 (en) 2000-12-06 2006-05-23 Novartis Ag Pharmaceutical compositions for the oral delivery of pharmacologically active agents
ES2199061B1 (es) * 2002-06-10 2005-02-16 Laboratorios Vita, S.A. Comprimidos bucodispersables y procedimiento para su obtencion.
US20040265372A1 (en) * 2003-06-27 2004-12-30 David Wynn Soft tablet containing high molecular weight cellulosics
WO2005065640A1 (en) * 2004-01-06 2005-07-21 Panacea Biotec Ltd. Compositions of buccal dosage forms for extended drug release and the process of preparing such compositions
US20060078623A1 (en) * 2004-08-13 2006-04-13 Emisphere Technologies, Inc. Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent
US8197858B2 (en) * 2009-02-06 2012-06-12 Mark John Zamoyski Bone microenvironment modulated seizure treatments
US9486947B2 (en) * 2013-09-30 2016-11-08 Gregory D. Graves Phosphorus treatment agent methods of manufacture and use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4151276A (en) * 1975-05-12 1979-04-24 Armour Pharmaceutical Company Method of suppressing gastric acid secretion by the oral administration of calcitonin
US4663309A (en) * 1983-06-29 1987-05-05 University Patents, Inc. Novel peptide hormones with calcitonin-like activity
US4530838A (en) * 1983-07-08 1985-07-23 The Salk Institute For Biological Studies Synthetic calcitonin-gene-related peptides for lowering blood pressure or gastric acid secretion in mammals
JPS61126034A (ja) * 1984-11-26 1986-06-13 Yamanouchi Pharmaceut Co Ltd アルド−スを含有するカルシトニン経鼻剤
US5288497A (en) * 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
JPS6210020A (ja) * 1985-07-08 1987-01-19 Kanebo Ltd カルシトニン含有組成物
IT1223132B (it) * 1987-11-13 1990-09-12 Isf Spa Composizione farmaceutica per somministrazione nasale
GB2212062B (en) * 1987-11-13 1991-07-17 Isf Spa Pharmaceutical compositions containing a calcitonin and a glycyrrhizinate ab- sorption enhancer

Also Published As

Publication number Publication date
US5441933A (en) 1995-08-15
CA2034519A1 (en) 1991-07-20
EP0438147A2 (en) 1991-07-24
MX24039A (es) 1994-02-28
EP0438147A3 (en) 1991-10-16
IT9019112A0 (it) 1990-01-19
IT9019112A1 (it) 1991-07-19
KR910014128A (ko) 1991-08-31
JPH04210924A (ja) 1992-08-03

Similar Documents

Publication Publication Date Title
IT8767796A0 (it) Forma farmaceutica di dosaggio per somministrazione orale con erogazione controllata di un ingrediente attivo
IT1173705B (it) Formulazione farmaceutica di clometacina per somministrazione orale e procedimento di preparazione
IT1191674B (it) Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale
ITBO910024A0 (it) Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale
FI950947L (fi) Oraalisesti annettavat farmaseuttiset formulaatiot
ITBO910113A0 (it) Formulazioni farmaceutiche per uso orale castroresistenti contenenti acidi biliari
FI955310L (fi) Farmaseuttinen koostumus flavonoidien antamiseksi oraalisesti
IT9019112A0 (it) Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina
ITMI921930A1 (it) Composizioni farmaceutiche per la somministrazione orale di diidropiridine in forma di bevanda
ITMI921123A0 (it) Formulazioni farmaceutiche orali contenenti antocianosidi
FI970331L (fi) Lääkkeen antokoostumus virustenvastaisten aineiden nenään toteutettavaa antoa varten
IT1206876B (it) Composizioni farmaceutiche a cessione prolungata relative forme di dosaggio e procedimento per la loro preparazione
NO950134D0 (no) Formuleringer for oralt administrerte farmasöytiske midler
IT1291340B1 (it) Formulazioni farmaceutiche contenenti colostro e uso del colostro per il trattamento di affezioni del cavo orale
IT1151953B (it) Composizione farmaceutica per la cura di affezioni della cavita' orale
IT8722031A0 (it) Formulazioni farmaceutiche e forme di dosaggio per la somministrazione rettale di calcitonina.
IT8621097A1 (it) Derivato di timo attivo per via orale, procedimenti per la sua preparazione e relative composizioni farmaceutiche
IT9021021A0 (it) Composizioni farmaceutiche per la somministrazione orale di irudina
ITMI911445A1 (it) Impiego di derivati fosfolipidici per la preparazione di composizioni farmaceutiche aventi attivita' immunosoppressiva
ITMI913510A1 (it) Composizioni farmaceutiche contenenti progesterone ad elevata biodisponibilita'
IT8922410A0 (it) Formulazioni farmaceutiche anidre e forme di dosaggio per la somministrazione rettale di calcitonina
IT1223132B (it) Composizione farmaceutica per somministrazione nasale
ITMI920214A1 (it) Composizioni farmaceutiche stabili per la somministrazione orale di calcitonina
ITPD920141A0 (it) Formulazione farmaceutiche per la somministraziane orale di calcitoni-na
IT1170255B (it) Composizione farmaceutica per la somministrazione orale di calcitonina

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19940203